1. Prescribed Minimum Benefits & Chronic Medication COUNCIL FOR MEDICAL SCHEMES

2. Prescribed Minimum Benefits (PMB’s) All medical schemes have to provide a basic set of benefits known as Prescribed minimum benefits- “270 treatment pairs” Schemes to pay the full cost of diagnosis, treatment and care thereof. Each option offered by a medical scheme must make provision for the PMB’s.

3. Objectives of the Prescribed Minimum Benefits Protects consumers from invisible limits to necessary benefits Prevent unfair discrimination on selected benefits Protect cover for necessary and high cost services Prevent dumping on the public health system Promote more appropriate behavior in benefit design, costing and management of cost

4. Preamble to Regulations “The objective of specifying a set of Prescribed Minimum Benefits within these regulations is two fold: 1.To avoid incidents where individuals lose their medical scheme cover in the event of serious illness and the consequent risk of unfunded utilization of public hospitals. 2. To encourage improved efficiency in the allocation of Private and Public health care resources”

5. The 15 PMB categories PMB CategoryExample Brain and nervous systemStroke EyeGlaucoma Ear, nose, mouth and throatCancer of oral cavity, pharynx, nose, ear, and larynx Respiratory systemPneumonia Heat and vasculature (blood vessels)Heart attacks Gastro-intestinal systemAppendicitis Liver, pancreas and spleenGallstones with cholecystitis Musculoskeletal system (muscles and bones); Trauma NOS Fracture of the hip Skin and breastTreatable breast cancer Endocrine, metabolic and nutritionalDisorders of the parathyroid gland Urinary and male genital systemEnd stage kidney disease Female reproductive systemCancer of the cervix, ovaries and uterus Pregnancy and childbirthAntenatal and obstetric care requiring hospitalisation, including delivery Haematological, infectious and miscellaneous systemic conditions HIV/Aids and TB Mental illnessShizophrenia Chronic conditionsAsthma, diabetes, epilepsy, hypothyroidism, schizophrenia, glaucoma, hypertension

6. HIV/AIDS PMB Diagnosis: HIV infection Treatment: –HIV voluntary counseling and testing –Co-trimoxazole as preventive therapy –Screening and preventive therapy for TB –Diagnosis and treatment of STIs –Pain management in palliative care –Treatment of opportunistic infections –Prevention of mother-to-child transmission of HIV –Post-exposure prophylaxis following occupational exposure or sexual assault Care : ARV’s

7. Applications Regulation 8 (1 January 2004) specifies: (1) Subject to the provisions of this regulation, any benefit option that is offered by a medical scheme must pay in full, without a co-payment or the use of deductibles, the diagnosis, treatment and care costs of the prescribed minimum benefit conditions

8. Chronic diseases 25 chronic diseases are included in the 270 PMB conditions Treatment algorithms were developed: –to manage risk –to ensure appropriate treatment standards –treatment covered by schemes may not be inferior to the algorithms Consultations & tests are also covered Protocols, formularies & designated service providers may be used to manage risk

9. Chronic Disease List  Addison’s Disease  Asthma  Bipolar Mood Disorder  Bronchiectasis  Cardiac Failure  Cardiomyopathy  Chronic Renal Disease  Chronic Obstructive Pulmonary Disease  Coronary Artery Disease  Crohn’s Disease  Diabetes Insipidus  Diabetes Mellitus Type 1 & 2  Dysrythmias  Epilepsy  Glaucoma  Haemophilia  Hyperlipidaemia  Hypertension  Hypothyroidism  Multiple Sclerosis  Parkinson’s Disease  Rheumatoid Arthritis  Schizophrenia  Systemic Lupus Erythematosus  Ulcerative Colitis

10. CDL: What members need to know Schemes can demand pre-authorisation or the joining of a benefit management programme Schemes may decide for which medicines it will pay, as long as they are at least on par with the published treatment standards Chronic medicine limits can still be set, but if limits are exhausted, schemes have to continue paying for chronic medication obtained from DSPs

11. Can my scheme refuse to cover my medication if I need, or want a brand other than that which the scheme says it will pay for? The scheme may refuse to cover all the expenses. When a formulary drug is clinically appropriate and effective; and the beneficiary knowingly declines; and ops to use another drug instead, the scheme may impose a co-payment

12. Yes, your scheme can set a limit for chronic medication, however if you exhaust the set limit for chronic medicine your scheme will have to continue paying for any chronic medication you obtain from its designated service provider for a PMB condition. Can schemes still set a chronic medicine limit?

13. Legal Framework Regulation 8 (1 January 2004) specifies: (1) Subject to the provisions of this regulation, any benefit option that is offered by a medical scheme must pay in full, without a co-payment or the use of deductibles, the diagnosis, treatment and care costs of the prescribed minimum benefit conditions

14. Legal Framework Managed Care Interventions (4)Medical schemes may employ…. appropriate interventions such as …. pre-authorisation, treatment protocols, formularies, etc. Formularies (5)When a formulary drug is clinically appropriate and effective; and the beneficiary knowingly declines; and ops to use another drug instead, the scheme may impose a co-payment

15. 15 H Protocols and 15 I Formularies: (a)… must be developed on the basis of evidence- based medicine, taking into account considerations of cost-effectiveness and affordability… (b)….must provide such protocol / formulary to health care providers, beneficiaries and members of the public, upon request,… (c)Provision must be made for appropriate exceptions / substitution…has been ineffective of causes or would cause harm to a beneficiary, without penalty to that beneficiary. Legal Framework

16. Co-payments Co-payments can be levied if members choose to use non-formulary medication and/or non-designated service providers Co-payments must be approved in rules Quantum to relate to difference between actual costs and preferred provider / reference price of formulary drug Co-payments may not be recovered out of savings accounts

17. What is a designated service provider? It is a healthcare provider/s (doctor, pharmacist, hospital etc) which is chosen by your medical scheme to be utilised as a preferred provider to its members when they need diagnosis, treatment or care for a PMB condition.

18. The role of Designated Service Providers (DSPs) DSP = medical scheme’s 1 st choice provider for PMB condition treatment May be state facilities, but not necessarily Scheme responsibilities: –ensure accessibility –ensure DSPs can deliver required services Non-DSP services are covered when: –DSPs are not accessible –DSPs cannot deliver –Emergency treatment is required

19. DSPs: Prevailing practices Schemes designate the public sector as DSP without ensuring reasonable availability & accessibility of services PMB service provision not arranged with public sector Responsibility to secure a bed in the public sector is shifted to beneficiaries Promoting unfunded utilisation of services in the public sector Members not fully informed about their DSP setting, particularly when it is the public sector

20. Proposed model for reimbursement of Prescribed Minimum Benefits Obtained from a designated (contracted) service provider (public/private)? YES NO NO co-payment Voluntary Involuntary Co-payments No co-payments

21. The message to your constituents 1.Confirm with your scheme that your condition is a PMB 2.Obtain the applicable rules from your scheme, i.e. protocols, formularies, DSPs, co-payments 3.Make sure your GP/specialist manage your treatment in terms of PMB rules & provisions 4.Adhere to your medical scheme’s rules applicable to your condition 5.Be an active consumer: ask questions, obtain 2 nd opinions, follow the complaints procedure

22. You could appeal If formulary medication is not effective beneficiaries can appeal to their schemes to approve alternative treatment Doctor needs to provide clinical history If successful, scheme will cover non-formulary treatment in full NOTE: personal preference is not grounds for appeal

23. THANK YOU!